v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO KNOW THE PITYRIASIS VERSICOLOR FREQUENCY IN DIABETES MELLITUS TYPE II PATIENTS WITH POOR COMPLIANCE

AUTHORS:

Dr. Mohammad Atiq ur Rehman, Dr. Imran Joher, Dr. Ahmed Raza

ABSTRACT:

Objective: The aim of the study was to determine the frequency of Pityriasis versicolor in type 2 diabetes mellitus patients with poor compliance. Study design: A cross-sectional study. Place and Duration: In the Dermatology department of Mayo Hospital, Lahore for one year duration from November 2017 to November 2018. Methods: Patients aged between 40 and 70 years in both genders with out of control diabetes mellitus were enrolled after informed consent. We excluded patients who received corticosteroids or immunosuppressive drugs or other accompanying patients. The selected subjects were evaluated with a magnifying glass and a wooden lamp. By Wood's lamp, microscopy and koh smears examination, diagnosis was confirmed. In a proforma, results were recorded. All results were tabulated, analyzed and compiled. Results: 119 patients (68 male (57%) and 51 female (43%) were selected for the study. Patients between the 40-70 years of age with 51.3 years mean age were analyzed and studied in the three age groups, namely > 60 years, 51-60 years and40-50 years. The majority of the patients (57%) were in the 40-50 age group. The diabetes mellitus duration was 5 to 10 years in the majority of patients, ie, 72 (3 male, 60%) and 2 females (40%) of these patients have tinea versicolor. Three of these patients had 5-10 years of diabetes and 2 patients had 11-15 years of same disease. Two patients (40%) from 40 to 50 years, 2 patients (40%) from 51 to 60 years, and 1 patient (20%) between 61 and 70 years. Conclusion: It can be concluded that Pityriasis versicolor is not common in diabetes mellitus patients. Key words: Diabetes mellitus, Tinea versicolor, Pityriasis versicolor.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.